13q mosaic deletion including RB1 associated to mild phenotype and no cancer outcome-case report and review of the literature 06 Biological Sciences 0604 Genetics

Ilaria Bestetti, Alessandra Sironi, Ilaria Catusi, Milena Mariani, Daniela Giardino, Siranoush Manoukian, Donatella Milani, Lidia Larizza, Chiara Castronovo, Palma Finelli

Research output: Contribution to journalReview article

Abstract

Background: The 13q deletion syndrome is a rare chromosome disorder associated with wide phenotypic spectrum, which is related to size and location of the deleted region and includes intellectual disability, growth retardation, craniofacial dysmorphisms, congenital malformations, and increased risk of retinoblastoma. Case presentation: Here, we report on a teenage boy with a mild phenotype characterized by obesity, hyperactivity, dysphagia, dysgraphia, sleep disturbance, and minor dysmorphic features (round face, bushy eyebrows, and stubby hands). Array Comparative Genomic Hybridization on blood identified a mosaic 13q14.13-13q31.1 deletion, with a mosaicism rate around 40%, which was confirmed by quantitative PCR and interphase Fluorescent In Situ Hybridization (iFISH) on both blood genomic DNA and cultured/uncultured blood lymphocytes, respectively. Conversely, karyotype analysis on blood estimated a mosaicism rate of 24% and iFISH on buccal smears revealed a borderline value of 0.4%, suggesting the absence of 13q deletion in this cell line. Conclusions: The comparison with previous patients carrying similar deletions informed that the proband clinical presentation is the mildest reported to date, thus supporting the burden of mosaicism in modulating the phenotype also in case of large chromosomal rearrangements. Characterization of further cases by in-depth mosaicism rate in tissues with different embryonic origins might contribute in the future to a better definition of genotype-phenotype correlation, including tumor risk.

LanguageEnglish
Article number53
JournalMolecular Cytogenetics
Volume11
Issue number1
DOIs
Publication statusPublished - Sep 19 2018

Fingerprint

Mosaicism
Biological Science Disciplines
Blood
Phenotype
Interphase
Fluorescence In Situ Hybridization
Neoplasms
Agraphia
Chromosome Disorders
Eyebrows
Comparative Genomic Hybridization
Lymphocytes
Retinoblastoma
Cheek
Genetic Association Studies
Chromosomes
Deglutition Disorders
Karyotype
Intellectual Disability
Tumors

Keywords

  • 13q deletion syndrome
  • Array CGH
  • Interphase FISH
  • Mosaicism
  • RB1

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Biochemistry, medical

Cite this

13q mosaic deletion including RB1 associated to mild phenotype and no cancer outcome-case report and review of the literature 06 Biological Sciences 0604 Genetics. / Bestetti, Ilaria; Sironi, Alessandra; Catusi, Ilaria; Mariani, Milena; Giardino, Daniela; Manoukian, Siranoush; Milani, Donatella; Larizza, Lidia; Castronovo, Chiara; Finelli, Palma.

In: Molecular Cytogenetics, Vol. 11, No. 1, 53, 19.09.2018.

Research output: Contribution to journalReview article

@article{bed786d96b7b431eb930c5b3b6af4860,
title = "13q mosaic deletion including RB1 associated to mild phenotype and no cancer outcome-case report and review of the literature 06 Biological Sciences 0604 Genetics",
abstract = "Background: The 13q deletion syndrome is a rare chromosome disorder associated with wide phenotypic spectrum, which is related to size and location of the deleted region and includes intellectual disability, growth retardation, craniofacial dysmorphisms, congenital malformations, and increased risk of retinoblastoma. Case presentation: Here, we report on a teenage boy with a mild phenotype characterized by obesity, hyperactivity, dysphagia, dysgraphia, sleep disturbance, and minor dysmorphic features (round face, bushy eyebrows, and stubby hands). Array Comparative Genomic Hybridization on blood identified a mosaic 13q14.13-13q31.1 deletion, with a mosaicism rate around 40{\%}, which was confirmed by quantitative PCR and interphase Fluorescent In Situ Hybridization (iFISH) on both blood genomic DNA and cultured/uncultured blood lymphocytes, respectively. Conversely, karyotype analysis on blood estimated a mosaicism rate of 24{\%} and iFISH on buccal smears revealed a borderline value of 0.4{\%}, suggesting the absence of 13q deletion in this cell line. Conclusions: The comparison with previous patients carrying similar deletions informed that the proband clinical presentation is the mildest reported to date, thus supporting the burden of mosaicism in modulating the phenotype also in case of large chromosomal rearrangements. Characterization of further cases by in-depth mosaicism rate in tissues with different embryonic origins might contribute in the future to a better definition of genotype-phenotype correlation, including tumor risk.",
keywords = "13q deletion syndrome, Array CGH, Interphase FISH, Mosaicism, RB1",
author = "Ilaria Bestetti and Alessandra Sironi and Ilaria Catusi and Milena Mariani and Daniela Giardino and Siranoush Manoukian and Donatella Milani and Lidia Larizza and Chiara Castronovo and Palma Finelli",
year = "2018",
month = "9",
day = "19",
doi = "10.1186/s13039-018-0401-5",
language = "English",
volume = "11",
journal = "Molecular Cytogenetics",
issn = "1755-8166",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - 13q mosaic deletion including RB1 associated to mild phenotype and no cancer outcome-case report and review of the literature 06 Biological Sciences 0604 Genetics

AU - Bestetti, Ilaria

AU - Sironi, Alessandra

AU - Catusi, Ilaria

AU - Mariani, Milena

AU - Giardino, Daniela

AU - Manoukian, Siranoush

AU - Milani, Donatella

AU - Larizza, Lidia

AU - Castronovo, Chiara

AU - Finelli, Palma

PY - 2018/9/19

Y1 - 2018/9/19

N2 - Background: The 13q deletion syndrome is a rare chromosome disorder associated with wide phenotypic spectrum, which is related to size and location of the deleted region and includes intellectual disability, growth retardation, craniofacial dysmorphisms, congenital malformations, and increased risk of retinoblastoma. Case presentation: Here, we report on a teenage boy with a mild phenotype characterized by obesity, hyperactivity, dysphagia, dysgraphia, sleep disturbance, and minor dysmorphic features (round face, bushy eyebrows, and stubby hands). Array Comparative Genomic Hybridization on blood identified a mosaic 13q14.13-13q31.1 deletion, with a mosaicism rate around 40%, which was confirmed by quantitative PCR and interphase Fluorescent In Situ Hybridization (iFISH) on both blood genomic DNA and cultured/uncultured blood lymphocytes, respectively. Conversely, karyotype analysis on blood estimated a mosaicism rate of 24% and iFISH on buccal smears revealed a borderline value of 0.4%, suggesting the absence of 13q deletion in this cell line. Conclusions: The comparison with previous patients carrying similar deletions informed that the proband clinical presentation is the mildest reported to date, thus supporting the burden of mosaicism in modulating the phenotype also in case of large chromosomal rearrangements. Characterization of further cases by in-depth mosaicism rate in tissues with different embryonic origins might contribute in the future to a better definition of genotype-phenotype correlation, including tumor risk.

AB - Background: The 13q deletion syndrome is a rare chromosome disorder associated with wide phenotypic spectrum, which is related to size and location of the deleted region and includes intellectual disability, growth retardation, craniofacial dysmorphisms, congenital malformations, and increased risk of retinoblastoma. Case presentation: Here, we report on a teenage boy with a mild phenotype characterized by obesity, hyperactivity, dysphagia, dysgraphia, sleep disturbance, and minor dysmorphic features (round face, bushy eyebrows, and stubby hands). Array Comparative Genomic Hybridization on blood identified a mosaic 13q14.13-13q31.1 deletion, with a mosaicism rate around 40%, which was confirmed by quantitative PCR and interphase Fluorescent In Situ Hybridization (iFISH) on both blood genomic DNA and cultured/uncultured blood lymphocytes, respectively. Conversely, karyotype analysis on blood estimated a mosaicism rate of 24% and iFISH on buccal smears revealed a borderline value of 0.4%, suggesting the absence of 13q deletion in this cell line. Conclusions: The comparison with previous patients carrying similar deletions informed that the proband clinical presentation is the mildest reported to date, thus supporting the burden of mosaicism in modulating the phenotype also in case of large chromosomal rearrangements. Characterization of further cases by in-depth mosaicism rate in tissues with different embryonic origins might contribute in the future to a better definition of genotype-phenotype correlation, including tumor risk.

KW - 13q deletion syndrome

KW - Array CGH

KW - Interphase FISH

KW - Mosaicism

KW - RB1

UR - http://www.scopus.com/inward/record.url?scp=85053706222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053706222&partnerID=8YFLogxK

U2 - 10.1186/s13039-018-0401-5

DO - 10.1186/s13039-018-0401-5

M3 - Review article

VL - 11

JO - Molecular Cytogenetics

T2 - Molecular Cytogenetics

JF - Molecular Cytogenetics

SN - 1755-8166

IS - 1

M1 - 53

ER -